Literature DB >> 20001339

Pseudomonas aeruginosa and the hyperlipidaemia of sepsis.

Rajkumar Cheluvappa1, Gerene M Denning, Gee W Lau, Michael C Grimm, Sarah N Hilmer, David G Le Couteur.   

Abstract

Pathophysiological alterations of liver sinusoidal endothelial cells (LSECs) impact liver and metabolism. LSEC fenestrations are pores facilitating lipoproteins and macromolecule transfer between blood and hepatocytes. The Gram negative bacterium Pseudomonas aeruginosa is one of the most common opportunistic nosocomial pathogens, especially in post-liver transplant recipients. Gram negative bacterial endotoxin (lipopolysaccharide, LPS) and the P. aeruginosa toxin, pyocyanin, have marked effects on LSECs, including loss of porosity (defenestration). Currently proposed mechanisms for sepsis-hyperlipidaemia, an important response to Gram negative bacterial sepsis, include tissue lipoprotein-lipase inhibition and increased hepatic triglyceride production. Owing to the well-substantiated role of LSECs in liver-allograft rejection and hyperlipidaemia, we propose defenestration of the LSEC is an additional cellular mechanism for sepsis-hyperlipidaemia, including pseudomonal sepsis post-liver transplantation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20001339     DOI: 10.3109/00313020903257764

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  3 in total

1.  Sepsis: multiple abnormalities, heterogeneous responses, and evolving understanding.

Authors:  Kendra N Iskander; Marcin F Osuchowski; Deborah J Stearns-Kurosawa; Shinichiro Kurosawa; David Stepien; Catherine Valentine; Daniel G Remick
Journal:  Physiol Rev       Date:  2013-07       Impact factor: 37.312

2.  Standardized chemical synthesis of Pseudomonas aeruginosa pyocyanin.

Authors:  Rajkumar Cheluvappa
Journal:  MethodsX       Date:  2014-07-08

3.  Beneficial effect of Xuebijing against Pseudomonas aeruginosa infection in Caenorhabditis elegans.

Authors:  Le Zhang; Yuxing Wang; Chang Cao; Yike Zhu; Wei Huang; Yi Yang; Haibo Qiu; Songqiao Liu; Dayong Wang
Journal:  Front Pharmacol       Date:  2022-08-31       Impact factor: 5.988

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.